General Use-results Survey of IMDELLTRA in Patients with Small Cell Lung Cancer Progressed after Cancer Chemotherapy (20230313)

Study identification

• EU PAS number:
  EUPAS1000000817
• Study ID:
  1000000817
• Official title and acronym:
  General Use-results Survey of IMDELLTRA in Patients with Small Cell Lung Cancer Progressed after Cancer Chemotherapy (20230313)
• DARWIN EU® study:
  No
• Study countries:
  Japan
• Study description:
  No information provided.
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Planned:01/11/2025

Study start date

Planned:31/03/2026

Actual:03/03/2026

Data analysis start date

Planned:01/11/2029

Date of final study report

Planned:31/12/2030

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only